Forbes Ranks Zimmer Among Best Managed Companies
July 28, 2016 at 4:25 p.m.
Forbes Magazine ranked Zimmer Holdings Inc. (NYSE and SWX: ZMH) among its Platinum 400 ("the Best Big Companies in America") and as one of the "Best Managed Companies in America" in its Jan. 12 edition.
The Forbes rankings were based on a study that analyzed 1,000 publicly traded companies for five-year total return, long- and short-term sales growth, earnings growth and independent earnings forecasts. Companies also were screened on factors such as accounting and governance, financial condition and earnings quality. The magazine ranked Zimmer's shareholder return first among three orthopedic companies and 21st among all 1,000 companies surveyed.
"Zimmer's consistently strong financial performance and acceptance by investors since we went public in 2001 is reflected in this ranking," said Ray Elliott, Zimmer's chairman, president and chief executive officer. "We hope to continue to earn such distinctions by capitalizing on our leadership in Minimally Invasive Solutionsª procedures and technologies and on the strategic benefits of our recent acquisition of Centerpulse AG."
With the acquisition, Zimmer became the world leader in orthopedic reconstructive products, became Europe's largest orthopedic company, and gained a platform in the fast-growing spinal products segment. The company also recently announced its planned acquisition of Implex Corp., the company that manufactures the innovative orthopedic material which Zimmer has sold as Trabecular Metalª Technology under a distribution agreement.
Zimmer's performance has been similarly recognized in other financial publications, including the December 2003 issue of MONEY Magazine, which selected Zimmer Holdings Inc. as one of 20 "Next Generation" Blue Chip stocks, and the June 2003 issue of BusinessWeek magazine, which profiled the company as one of its Top 100 "Hot Growth" companies.
Zimmer also announced Friday it will be participating in the Merrill Lynch global Pharmaceutical, Biotechnology and Medical Device Conference in New York City on Thursday. Ray Elliott, chairman, president and CEO of Zimmer Holdings is scheduled to present on the company's business at 8:10 a.m.
The presentation can be accessed live via the Merrill Lynch Conference Web site at http/w.on24,com/r.htm?e=4522&k+700C58611871254FBE8D8C5F2E2C7642&s=91&presenter+zimmerholdi or via the Zimmer Web site, www.zimmer.com (Investor Relations section). The presentaton will be archived on both Web sites for replay following the conference. [[In-content Ad]]
Forbes Magazine ranked Zimmer Holdings Inc. (NYSE and SWX: ZMH) among its Platinum 400 ("the Best Big Companies in America") and as one of the "Best Managed Companies in America" in its Jan. 12 edition.
The Forbes rankings were based on a study that analyzed 1,000 publicly traded companies for five-year total return, long- and short-term sales growth, earnings growth and independent earnings forecasts. Companies also were screened on factors such as accounting and governance, financial condition and earnings quality. The magazine ranked Zimmer's shareholder return first among three orthopedic companies and 21st among all 1,000 companies surveyed.
"Zimmer's consistently strong financial performance and acceptance by investors since we went public in 2001 is reflected in this ranking," said Ray Elliott, Zimmer's chairman, president and chief executive officer. "We hope to continue to earn such distinctions by capitalizing on our leadership in Minimally Invasive Solutionsª procedures and technologies and on the strategic benefits of our recent acquisition of Centerpulse AG."
With the acquisition, Zimmer became the world leader in orthopedic reconstructive products, became Europe's largest orthopedic company, and gained a platform in the fast-growing spinal products segment. The company also recently announced its planned acquisition of Implex Corp., the company that manufactures the innovative orthopedic material which Zimmer has sold as Trabecular Metalª Technology under a distribution agreement.
Zimmer's performance has been similarly recognized in other financial publications, including the December 2003 issue of MONEY Magazine, which selected Zimmer Holdings Inc. as one of 20 "Next Generation" Blue Chip stocks, and the June 2003 issue of BusinessWeek magazine, which profiled the company as one of its Top 100 "Hot Growth" companies.
Zimmer also announced Friday it will be participating in the Merrill Lynch global Pharmaceutical, Biotechnology and Medical Device Conference in New York City on Thursday. Ray Elliott, chairman, president and CEO of Zimmer Holdings is scheduled to present on the company's business at 8:10 a.m.
The presentation can be accessed live via the Merrill Lynch Conference Web site at http/w.on24,com/r.htm?e=4522&k+700C58611871254FBE8D8C5F2E2C7642&s=91&presenter+zimmerholdi or via the Zimmer Web site, www.zimmer.com (Investor Relations section). The presentaton will be archived on both Web sites for replay following the conference. [[In-content Ad]]